Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 136.22

-0.8%

Jan 23 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (1229)	5/4/2004 1:46:24 PM
From: quidditch	Read Replies (1) of 1834

And I was thinking of selling cc's at $68. Rats. In any event, a number of interesting things flow from that squib: - obvious that this was disseminated internally about a week ago - curious about the delay--P3 trial results seemed to be very positive, and Estorra's approvable seemed to remove remaining doubts about the ER formulation and a LT label (although SEPR has dawdled in its re-submission--doesn't make sense in terms of management's touting the real possibility of a Class 1)--is this agency at work or PFE/NBIX? - EPS estimate for 2005 is now $2.94????? from $2.55?? Where are they getting these numbers and time frame? Must be typos here - mentions that current valuation fairly reflects earnings potential of indiplon only and says nothing about rest of the pipe quid

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next